Development of Stroke Prognosis Predictive Precision Medicine Based on a Digital Twin
Recruiting now
Conditions studied: Stroke
In brief
To collect large-scale, high-quality clinical data, daily activity and movement patterns, and genomic information from stroke patients spanning the subacute to chronic stages. This study aims to establish the foundation for personalized precision medicine in stroke care and to develop a visual and digital transformation of patient medical information in the era of digital healthcare.
Key facts
- Study ID
- NCT07482579
- Run by
- Seyoung Shin
- People needed
- 70
- Starts
- 2025-11-01
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-03-25
Who can join
Age: 20 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults aged 20 years or older with a confirmed diagnosis of stroke.
- Within 1 month after stroke onset.
- Patients scoring between 0 and 3 points on the Functional Ambulatory Category (FAC) test.
- Patients or their legally authorized representatives who have fully understood the details of this study, voluntarily decided to participate, and provided written informed consent to comply with the study instructions.
You may not qualify if…
- Patients with impaired ability to provide consent (MMSE score less than 10) who are not accompanied by a caregiver.
- Any other cases deemed inappropriate for participation by the investigator. (This study is non-interventional; therefore, patients who are currently participating in or have participated in another clinical study or research within the past 30 days may still be included.)
Where it is running
- Bundang CHA Medical Center — Gyeonggi-do, Gyeonggi-do, South Korea (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.